Tacrolimus in corticosteroid-resistant ulcerative colitis

Journal of Gastroenterology

Volumn 35, Issue 8, 2000, Pages 635-640

  Matsuhashi, Nobuyuki ^a   Nakajima, Atsushi ^a   Watanabe, Kiyotaka ^a   Komeno, Yukiko ^a   Suzuki, Atsushi ^a   Ohnishi, Shin ^a   Omata, Masao ^a   Kondo, Kenji ^b   Usui, Yoshiki ^b   Iwadare, Jun Ichi ^b   Watanabe, Toshiaki ^a   Nagawa, Hirokazu ^a   Muto, Tetsuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Social Hlth Ins Medical Center   (Japan)

Author keywords

Crohn's disease; Cyclosporine A; Immunosuppressant; Tacrolimus; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTAPHERESIS; DRUG EFFICACY; FEMALE; HUMAN; LEUKOCYTE; LIVER INJURY; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0033845828     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070065     Document Type: Article

References (22)

1. Cyclosporine A in ulcerative colitis
2. Cyclosporine A in severe ulcerative colitis refractory to steroid therapy
3. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
4. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients
5. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506)
6. Tacrolimus (FK-506) treatment of fulminant colitis in a child
7. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease
8. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
9. Cyclosporine therapy for autoimmune disease
10. Mesalamine capsules for treatment of active ulcerative colitis: Results of a controlled trial. Pentasa Study Group
11. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B
12. The mechanism of action of cyclosporin A and FK506
13. Biology of cyclosporin A and FK506
14. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation
15. Effects of cyclosporine A on thymocyte differentiation in fetal thymus organ culture
16. Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction
17. Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506
18. FK 506: A novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh
19. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
20. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis